H19 silencing has been shown to enhance TMZ cytotoxicity in glioma cells through inhibiting epithelial-mesenchymal transition (EMT) via the Wnt/β-catenin pathway (11) and inactivating NF-kB signaling (23). Here, H19 is linked to central nervous system cancer.